患有良性前列腺增生和雄激素脱发症的费纳斯特使用者的精神疾病风险:基于人口的病例对照研究
Anna Lyakhovitsky1,2, Boaz Amichai2,3, Eran Galili1,2
1Department of Dermatology, Sheba Medical Center, Ramat-Gan, Israel.
The Australasian journal of dermatology
|August 14, 2024
概括
在治疗良性前列腺增生症 (BPH) 时,使用费纳斯特并没有增加精神病学副作用. 然而,用于治疗雄激素脱发症 (AGA) 的费纳斯特与焦虑和抑郁率略有上升有关.
科学领域:
- 药理学和精神病学 药理学和精神病学
- 流行病学 流行病学
- 皮肤病学 皮肤病学
背景情况:
- 调查了关于费纳斯特的辩论精神病学副作用,费纳斯特是一种治疗良性前列腺增生症 (BPH) 和雄激素脱发症 (AGA) 的药物.
- 检查了费纳斯特治疗与精神健康状况的发展之间的关联.
研究的目的:
- 为了确定费纳斯特治疗BPH和AGA是否与新的心理健康状况有关.
- 分析与对照人群相比,费纳斯特使用者的心理结果发生率.
主要方法:
- 观察性病例对照研究,将费纳斯特使用者 (BPH和AGA) 与匹配的对照人群进行比较.
- 评估抑郁症,焦虑症,神经病,双相情感障碍,精神分裂症,精神病和酒精滥用在费纳斯特开始后的两年内.
主要成果:
- 与对照组相比,BPH组 (307名患者) 的心理健康结果没有显著增加.
- AGA组 (23,227名患者) 在焦虑 (0.6%对0.4%) 和抑郁 (0.5%对0.4%) 中略有增加.
- 在AGA患者中,费纳斯特被确定为焦虑 (OR 1.449) 和抑郁症 (OR 1.439) 的风险因素.
结论:
- 费纳斯特使用者经历了较低的不良心理健康影响率.
- 在BPH患者中没有观察到增加的心理后果.
- 在接受费纳斯特治疗的AGA患者中,观察到焦虑和抑郁症的轻微增加.
相关概念视频
Disorders of the Male Reproductive System
367
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
367
Anxiolytic Drugs: Benzodiazepines and Buspirone
596
Benzodiazepines are a class of anxiolytic drugs known for their rapid efficacy and high therapeutic-to-lethal dose ratio, but with a potential risk of drug dependence. These drugs are lipophilic, allowing for rapid absorption after oral administration, eventually reaching the central nervous system (CNS). Once in the CNS, benzodiazepines bind to the allosteric site of the GABAA receptor. This binding enhances the inhibitory effects of the neurotransmitter GABA. By doing so, they prevent...
596
Panic Disorder
53
Panic disorder is an anxiety disorder characterized by recurrent and sudden minutes-long episodes of intense fear, known as panic attacks. These attacks may feel like heart attacks and often happen without warning or a specific cause. They can include symptoms such as rapid heart rate, shortness of breath, chest pain, trembling, sweating, dizziness, and a sense of helplessness. During a panic attack, individuals may feel as though they are experiencing a heart attack or are in a...
53
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
104
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
104
Bipolar Disorder
60
Bipolar disorder is a chronic mental health condition marked by significant mood fluctuations, including episodes of mania and depression. Elevated energy levels, heightened mood or irritability, impulsive behavior, reduced sleep needs, rapid speech, racing thoughts, inflated self-esteem, and distractibility characterize mania. Individuals with bipolar disorder often alternate between depressive and manic states, with periods of emotional stability lasting an average of six months to a year.
60
Antidepressant Drugs: MAOIs and Other Agents
209
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
209


